Literature DB >> 18953456

A near-fatal case of sepsis with an antibiotic-resistant organism complicating a routine transrectal prostate biopsy in a health care worker.

Bryce Weber1, John Saliken, Taj Jadavji, Robin R Gray, Ron Moore.   

Abstract

A 58-year-old physician with an elevated prostate specific antigen developed severe septic shock following a repeat transrectal prostate biopsy despite standard preoperative prophylactic protocol. This case highlights the significance of harbouring antibiotic-resistant bacteria and the risk of previous quinolone exposure. We believe this case may herald a rare but potentially serious consequence of increasingly common antibiotic resistance and that high-risk patients should be studied to determine their likelihood of carrying antibiotic-resistant flora in their genitourinary/gastrointestinal tract.

Entities:  

Year:  2008        PMID: 18953456      PMCID: PMC2572246          DOI: 10.5489/cuaj.926

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  13 in total

1.  Role of hand contamination of personnel in the epidemiology of gram-negative nosocomial infections.

Authors:  M A Knittle; D V Eitzman; H Baer
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

2.  Failure of ciprofloxacin prophylaxis for ultrasound guided transrectal prostatic biopsy in the era of multiresistant enterobacteriaceae.

Authors:  J Gilad; A Borer; N Maimon; K Riesenberg; M Klein; F Schlaeffer
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

3.  Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.

Authors:  K J Henning; H Delencastre; J Eagan; N Boone; A Brown; M Chung; N Wollner; D Armstrong
Journal:  Pediatr Infect Dis J       Date:  1996-10       Impact factor: 2.129

4.  Transrectal ultrasound examination of the prostate: complications and acceptance by patients.

Authors:  G Aus; C G Hermansson; J Hugosson; K V Pedersen
Journal:  Br J Urol       Date:  1993-04

5.  Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination.

Authors:  G Vallancien; D Prapotnich; B Veillon; J M Brisset; J Andre-Bougaran
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

6.  Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison.

Authors:  R W Haley; D R Schaberg; K B Crossley; S D Von Allmen; J E McGowan
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

7.  Hand carriage of gram-negative bacilli and Staphylococcus aureus.

Authors:  J N Bruun; C O Solberg
Journal:  Br Med J       Date:  1973-06-09

8.  Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.

Authors:  J Carratala; A Fernandez-Sevilla; F Tubau; M A Dominguez; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections.

Authors:  C Peña; J M Albareda; R Pallares; M Pujol; F Tubau; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

10.  Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus.

Authors:  D Rimland; B Roberson
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

View more
  3 in total

1.  Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies.

Authors:  Paul Toren; Roshan Razik; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

2.  Comparison between ciprofloxacin and trimethoprim-sulfamethoxazole in antibiotic prophylaxis for transrectal prostate biopsy.

Authors:  Doğan Atılgan; Yusuf Gençten; Engin Kölükçü; Şahin Kılıç; Nihat Uluocak; Bekir Süha Parlaktaş; Fikret Erdemir
Journal:  Turk J Urol       Date:  2015-03

3.  A prospective treatment for sepsis.

Authors:  Mohammad Rashid Shahidi Bonjar; Leyla Shahidi Bonjar
Journal:  Drug Des Devel Ther       Date:  2015-05-06       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.